Motor Oil Group CIO Nick Giannakakis interview: On digital transformation, Covid, and edge computing 23 Jun 2020
TLC doses first patients in Phase I/II study of TLC590 Taiwan Liposome Company (TLC) has dosed the first patients in a Phase I/II trial to... 15th August 2018